scispace - formally typeset
M

Massimo Faustini

Researcher at University of Milan

Publications -  136
Citations -  2313

Massimo Faustini is an academic researcher from University of Milan. The author has contributed to research in topics: Sperm & Semen. The author has an hindex of 23, co-authored 129 publications receiving 1983 citations. Previous affiliations of Massimo Faustini include University of Bologna & University of Salerno.

Papers
More filters
Journal ArticleDOI

An Apgar scoring system for routine assessment of newborn puppy viability and short-term survival prognosis.

TL;DR: A modified Apgar scoring system was used to assess newborn viability and short-term survival prognosis, as well as related characteristics, in 193 puppies from 42 litters, 65 born by spontaneous delivery, 66 by assisted delivery, and 62 by cesarean section.
Journal ArticleDOI

Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues.

TL;DR: Evidence is put in evidence that in males the best collection site in terms of yield is located in the abdomen, whereas in females the biopsy region do not influence cell recovery; the collection technique, the age, and the body mass index of donor seem not to influence the cell yield.
Journal ArticleDOI

Effect of semen preparation on casa motility results in cryopreserved bull spermatozoa.

TL;DR: It is proposed that the CASA evaluation of motility of bovine frozen-thawed semen using Hamilton-Thorne IVOS 12.3 should be performed using a frame rate of 60 frame/s and 30 frames per field, regardless of the chamber used.
Journal ArticleDOI

Alginate cell encapsulation: new advances in reproduction and cartilage regenerative medicine

TL;DR: The SVF represents a rich source of mesenchymal cells potentially able to differentiate into adipocytes, chondrocytes, osteoblasts, myocytes, cardiomyocytes, hepatocytes, and neuronal, epithelial and endothelial cells, which are ideal candidates for use in regenerative medicine, tissue engineering, including gene therapy and cell replacement cancer therapies.